Onconetix (ONCO) EPS (Basic) (2021 - 2026)
Onconetix (ONCO) posted quarterly EPS (Basic) of -$67.06 for Q1 2026, up 97.05% year-over-year from -$34.03 in Q1 2025, and down 122.18% quarter-over-quarter from $302.32 in Q4 2025.
Onconetix (ONCO) EPS (Basic) (2021 - 2026) Analysis & Trends
Onconetix (ONCO) has reported EPS (Basic) for 6 consecutive years, with -$67.06 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 97.05% year-over-year to -$67.06; the TTM figure through Mar 2026 stood at -$159.58 (up 98.81% YoY), while the FY2025 annual figure was -$828.14, up 99.09% from the prior year.
- EPS (Basic) eased to -$67.06 in Q1 2026 per ONCO's latest filing, from $302.32 in the prior quarter.
- Across five years, EPS (Basic) topped out at $302.32 in Q4 2025 and bottomed at -$221295.8 in Q4 2023.
- Historically, EPS (Basic) has averaged -$49503.9 across 5 years, with a median of -$45889.7 in 2024.
- Annual changes were most pronounced in 2023 — EPS (Basic) slumped 395.14% — and 2025, when it soared 100.66%.
- Onconetix's EPS (Basic) stood at -$44693.4 in 2022, then plunged by 395.14% to -$221295.8 in 2023, then jumped by 79.26% to -$45889.7 in 2024, then jumped by 100.66% to $302.32 in 2025, then tumbled by 122.18% to -$67.06 in 2026.
- Business Quant data shows ONCO's EPS (Basic) at -$67.06 in Q1 2026, $302.32 in Q4 2025, and -$312.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.18 |
| 10 | Onconetix | 1.43 Mn | -4.51 Mn | 4,303.00 | -1.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.28 |
| Mar 31, 2026 | -67.06 |
| Dec 31, 2025 | 302.32 |
| Sep 30, 2025 | -312.49 |
| Jun 30, 2025 | -237.91 |
| Mar 31, 2025 | -2,272.74 |
| Dec 31, 2024 | -45,889.70 |
| Sep 30, 2024 | -12,467.12 |
| Jun 30, 2024 | -109,211.48 |
| Mar 31, 2024 | -85,527.48 |
| Dec 31, 2023 | -221,295.76 |
| Sep 30, 2023 | -51,911.73 |
| Jun 30, 2023 | -73,034.79 |
| Mar 31, 2023 | -30,283.45 |
| Dec 31, 2022 | -44,693.40 |
| Sep 30, 2022 | -46,031.69 |
| Jun 30, 2022 | -60,064.54 |
| Mar 31, 2022 | -58,568.11 |
| Dec 31, 2021 | -71,974.84 |
| Sep 30, 2021 | -67,486.53 |